Nadine Abi-Jaoudeh, MD, is an American and Canadian board-certified vascular and interventional radiologist at the University of California Irvine. Dr. Abi-Jaoudeh earned her medical degree from the University of Montreal and her completed internship and residency at the University of Laval in Québec, Canada, and a fellowship in interventional radiology at the University of Virginia in Charlottesville, Virginia. She then joined the National Institutes of Health where she was a principal and associate investigator on several human trials. She also completed multiple animal and translational studies. In 2015, Dr. Abi-Jaoudeh joined the University of California Irvine where she has grown the research program. In 2018, she became the director of clinical research of the department of radiology. She is principal investigator on multiple Phase I, II and III trials.
Her clinical interests include minimally invasive image guided interventions, including but not limited to, vascular and non-vascular oncological interventions.
She has authored multiple manuscripts and submitted two patents related to imaging technology in the angiography suite. Her research interests include fusion and functional imaging during image guided procedures, innovative therapeutic methods to treat metastatic and primary liver disease. Her goal is to grow a translational research program to improve UCI patient care and outcome.
Dr. Abi-Jaoudeh is a fellow of the Society of Interventional Radiology, a member of the Royal Canadian College of Radiology, and associate editor of the Journal of Vascular and Interventional Radiology. She is also on the scientific committee of the Society of Interventional Radiology annual meeting.
Tiffany Brosius, RN, BSN, OCN, is a nurse navigator working with patients with gastrointestinal malignancies at Winship Cancer Institute.
An oncology-certified nurse, Mrs. Brosius began her nursing career as an outpatient chemotherapy infusion nurse at University Cancer and Blood Center in Athens, Georgia. She relocated to Atlanta, Georgia, and accepted a position as a Nurse Clinician on the medical oncology floor at Emory University Hospital. She then transitioned back to the outpatient setting to continue her nursing career as an Advanced Nurse Clinician at Winship Cancer Institute, focusing on gastrointestinal malignancies. In this role, she assisted patients with symptom management and chemotherapy education.
She is a local and national member of the Oncology Nursing Society and was recently accepted as a member to Sigma Theta Tau International Honor Society, Alpha Epsilon Chapter at Emory University.
She received a Bachelor of Science in Nursing from Georgia Regents University, formerly known as the The Medical College of Georgia.
Matthew Dugan, DO, is a medical oncologist at New England Cancer Specialists, where he specializes in all cancers of the digestive system, and head and neck. Dr. Dugan serves as an associate instructor for Tufts University School of Medicine, the University of Vermont, and the University of New England. Principal investigator on multiple industry and cooperative group clinical trials, Dr. Dugan has also published works in the New England Journal of Medicine and Cancer Investigation.
Catherine Frenette, MD, is the director of the liver and hepatocellular cancer program at Scripps MD Anderson Cancer Center, and the medical director of liver transplantation at the Scripps Center for Organ Transplantation at Scripps Green Hospital. She is dedicated to providing comprehensive, compassionate care to patients who have liver disease or liver disorders, including cirrhosis, hepatitis, and liver cancer.
Dr. Frenette understands liver disease is a complex process that requires a team approach to diagnosis and care. She approaches each patient as a partner in his or her own care. Dr. Frenette holds special clinical interest and expertise in liver transplantation to treat cirrhosis, hepatocellular carcinoma (liver cancer), autoimmune hepatitis, viral hepatitis, acute liver failure, and end-stage liver disease.
In her practice, Dr. Frenette provides comprehensive evaluation and treatment for liver problems including primary biliary cirrhosis, hepatocellular carcinoma, primary sclerosing cholangitis, hemochromatosis, Wilson’s disease, fatty liver disease, alcoholic liver disease, and acute liver failure.
With a combination of compassionate care, leading-edge expertise, and widely recognized medical leadership, Dr. Frenette leads the Scripps liver transplant team’s efforts to help improve outcomes and save lives.
Anurag Maheshwari, MD, specializes in liver disease at the Center for Liver and Hepatobiliary Diseases, part of the Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy Medical Center in Baltimore, Maryland. His expertise helps patients in the diagnosis and treatment of liver diseases.
Dr. Maheshwari helps patients in need of liver transplants and assists in pre- and post-operative transplant medical care, providing each patient individualized attention, coordination with liver transplant centers, and understanding as they progress toward recovery.
Dr. Maheshwari is active in advanced research projects in liver diseases, having authored numerous peer-reviewed publications and book chapters on issues in liver disease.
Dr. Philip is a Kathryn Cramer MD Endowed Professor in Cancer Research at the Wayne State University School of Medicine and the leader of the GI and neuroendocrine multidisciplinary team and Vice President of medical affairs at the Karmanos Cancer Institute. He is also a fellow of the Royal College of Physicians in the UK and Chair of the pancreatic cancer committee at the Southwest Oncology Group (SWOG). An internationally-recognized lecturer, Dr. Philip is known for his research in the development of new therapies for gastrointestinal and neuroendocrine cancers.
Donna R. Cryer, JD, is president and chief executive officer of the Global Liver Institute, the innovation and collaboration platform for liver health worldwide. An attorney and award-winning patient advocate, she is an entrepreneurial business executive with expertise in digital health, precision medicine, drug development, and health policy.
For more than a decade, Mrs. Cryer led CryerHealth, a healthcare consulting firm she founded, providing strategic counsel to top biopharmaceutical companies, patient advocacy organizations, and emerging technology firms on patient engagement in health information technology, drug discovery, and clinical decision-making.
Mrs. Cryer serves on the executive committees of the People Centered Research Foundation and the Clinical Trials Transformation Initiative, as well as on the executive advisory board for Tivity Health.
She has been named one of the “Top Blacks in Healthcare” by the Milken Institute at GW School of Public Health and BlackDoctor.org, one of the “Top 10 Patients Who Make an Impact” by Health 2.0, and one of PharmaVoice’s “100 Most Inspiring People.”
Hildy Dillon, MPH, is the vice president of education and support programs for Cancer Support Community (CSC), where she oversees CSC programs and services for people living with cancer, their caregivers, and loved ones. This includes education and outreach, the Cancer Support Helpline, online virtual support services, programmatic professional training and program development, and dissemination across CSC’s affiliate network and beyond.
Hildy has decades of leadership experience in the non-profit sector in patient and professional advocacy and education. She has a global reputation for building positive alliances among patients, clinicians, research scientists, pharmaceutical and biotech, government, and professional organizations. Respected for her expertise in the clinical development of therapeutics and diagnostics, Hildy serves in an advisory capacity to many pharmaceutical and biotech companies addressing issues of patient access, adherence, and patient-centered outcomes.